Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
---|---|---|---|---|
T47D | GSK2334470 | 3.16227766 | 0.3785 | 0.03226 |
T47D | GSK2334470 | 3.16227766 | 0.3674 | 0.01506 |
T47D | GSK2334470 | 10.0 | 0.2553 | 0.04276 |
T47D | GSK2334470 | 10.0 | 0.1531 | 0.00986 |
T47D | GSK2334470 | 10.0 | 0.1652 | 0.00308 |
T47D | Ribociclib | 0.001 | 0.6347 | 0.01723 |
T47D | Ribociclib | 0.001 | 0.5735 | 0.00149 |
T47D | Ribociclib | 0.001 | 0.6134 | 0.01237 |
T47D | Ribociclib | 0.003162278 | 0.6931 | 0.00929 |
T47D | Ribociclib | 0.003162278 | 0.4882 | 0.00165 |
T47D | Ribociclib | 0.003162278 | 0.6217 | 0.01090 |
T47D | Ribociclib | 0.01 | 0.4147 | 0.01806 |
T47D | Ribociclib | 0.01 | 0.3358 | 0.00266 |
T47D | Ribociclib | 0.01 | 0.4500 | -0.00009 |
T47D | Ribociclib | 0.031622777 | 0.97867 | |
T47D | Ribociclib | 0.031622777 | 0.3993 | 0.00852 |
T47D | Ribociclib | 0.031622777 | 0.3858 | 0.01448 |
T47D | Ribociclib | 0.1 | 0.1952 | 0.05326 |
T47D | Ribociclib | 0.1 | 0.3321 | 0.00274 |
T47D | Ribociclib | 0.1 | 0.2954 | 0.03838 |
T47D | Ribociclib | 0.316227766 | 0.3153 | 0.00587 |
T47D | Ribociclib | 0.316227766 | 0.2320 | 0.03694 |
T47D | Ribociclib | 0.316227766 | 0.2054 | 0.06948 |
T47D | Ribociclib | 1.0 | 0.1652 | 0.04200 |
T47D | Ribociclib | 1.0 | 0.1537 | 0.03059 |